MEK/ERK Dependent Activation of STAT1 Mediates Dasatinib-Induced Differentiation of Acute Myeloid Leukemia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MEK/ERK Dependent Activation of STAT1 Mediates Dasatinib-Induced Differentiation of Acute Myeloid Leukemia
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 6, Pages e66915
Publisher
Public Library of Science (PLoS)
Online
2013-06-26
DOI
10.1371/journal.pone.0066915
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: Delineation of anti-leukemic mechanisms of action
- (2011) Elodie Lainey et al. BIOCHEMICAL PHARMACOLOGY
- Acquired resistance to drugs targeting receptor tyrosine kinases
- (2011) Steven A. Rosenzweig BIOCHEMICAL PHARMACOLOGY
- Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor
- (2011) M. S. Redell et al. BLOOD
- The ubiquitin-proteasome pathway plays essential roles in ATRA-induced leukemia cells G0/G1phase arrest and transition into granulocytic differentiation
- (2011) Yanfen Fang et al. CANCER BIOLOGY & THERAPY
- Nilotinib and MEK Inhibitors Induce Synthetic Lethality through Paradoxical Activation of RAF in Drug-Resistant Chronic Myeloid Leukemia
- (2011) Leisl M. Packer et al. CANCER CELL
- Therapeutic Advances in Acute Myeloid Leukemia
- (2011) Alan Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Severe acute respiratory syndrome coronavirus papain-like protease suppressed alpha interferon-induced responses through downregulation of extracellular signal-regulated kinase 1-mediated signalling pathways
- (2011) S.-W. Li et al. JOURNAL OF GENERAL VIROLOGY
- Evolving treatment strategies for patients newly diagnosed with chronic myeloid leukemia: the role of second-generation BCR–ABL inhibitors as first-line therapy
- (2011) P J Shami et al. LEUKEMIA
- Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells
- (2011) J Congleton et al. LEUKEMIA
- The Tyrosine Kinase Inhibitor Dasatinib Induces a Marked Adipogenic Differentiation of Human Multipotent Mesenchymal Stromal Cells
- (2011) Adriana Borriello et al. PLoS One
- The Proteasome Inhibitor Bortezomib Enhances ATRA-Induced Differentiation of Neuroblastoma Cells via the JNK Mitogen-Activated Protein Kinase Pathway
- (2011) Peihua Luo et al. PLoS One
- Systems biology of JAK-STAT signalling in human malignancies
- (2011) Julio Vera et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Targeted therapy of chronic myeloid leukemia
- (2010) Con Sullivan et al. BIOCHEMICAL PHARMACOLOGY
- STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells
- (2010) I. Hazan-Halevy et al. BLOOD
- Dasatinib Inhibits the Growth of Molecularly Heterogeneous Myeloid Leukemias
- (2010) B. S. Guerrouahen et al. CLINICAL CANCER RESEARCH
- PU.1 directly regulates retinoic acid-induced expression of RIG-G in leukemia cells
- (2010) Zhi-Min Gu et al. FEBS LETTERS
- Robust in vivo differentiation of t(8;21)-positive acute myeloid leukemia blasts to neutrophilic granulocytes induced by treatment with dasatinib
- (2010) N Chevalier et al. LEUKEMIA
- Inhibition of all-Trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells
- (2010) Yanfen Fang et al. MOLECULAR CARCINOGENESIS
- Differentiation therapy of leukemia: 3 decades of development
- (2009) D. Nowak et al. BLOOD
- Differentiation therapy of acute myeloid leukemia: past, present and future
- (2009) Kevin Petrie et al. CURRENT OPINION IN HEMATOLOGY
- PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling
- (2009) S. Weber et al. GENES & DEVELOPMENT
- Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias
- (2009) Mustafa Benekli et al. JOURNAL OF CLINICAL ONCOLOGY
- Dasatinib promotes ATRA-induced differentiation of AML cells
- (2009) P L Kropf et al. LEUKEMIA
- A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects
- (2008) B. J. Wouters et al. BLOOD
- Acute promyelocytic leukemia: from highly fatal to highly curable
- (2008) Z.-Y. Wang et al. BLOOD
- Gefitinib potentiates myeloid cell differentiation by ATRA
- (2008) M B Miranda et al. LEUKEMIA
- Initial testing of dasatinib by the pediatric preclinical testing program
- (2007) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search